NeuroOne Corp (NMTC): Utang-utang marang kapitalisasi buku

Tandha merek NeuroOne (NMTC)

Can NeuroOne Medical Technologies (NMTC) overcome unprofitability caused by slow hospital procurement and R&D costs? Stability is provided by the Minnesota plant featuring autonomous power and climate control. The allocation of debt capital within the balance sheet capitalization confirms niche superiority in epilepsy and Parkinson's therapy, while the level of 0.05 represents the current value of this metric.

NMTC - Utang-utang marang aset resik NeuroOne Medical Technologies Corp. ing rentang 04.07.2022 - 27.10.2026

Rincian metrik lan analitis perusahaan NeuroOne (NMTC)

- rega lan prakiraan konsensus rega:
Rega saham NeuroOne Medical Technologies|NMTC - Rata-rata rega prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar NeuroOne Medical Technologies Corp.|NMTC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Nilai Buku saben Saham NeuroOne Medical Technologies|NMTC - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku n1mtc.com|NMTC - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas NeuroOne Medical Technologies|NMTC - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NeuroOne Corp|NMTC - Gunggung kewajiban utang perusahaan|Utang marang nilai buku NeuroOne Medical Technologies Corp.
Analisis kabeh metrik perusahaan:NeuroOne Medical Technologies
Produk asli NeuroOne

Monitoring the debt-to-equity ratio confirms the status of NeuroOne Medical Technologies (NMTC) as a developer of high-tech medical devices. This indicator compares total liabilities with net assets, determining the transformation vector of the asset structure. The current value of 0.05 reflects the business's degree of dependence on borrowed funds. An increase in this metric may signal a squeeze on profitability due to product certification costs. A low level of this indicator guarantees stability during electronics supply chain disruptions.

Pesaing NeuroOne Medical Technologies

BSX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku edwards.com EW|RMD: Utang-utang marang kapitalisasi buku|PODD - Utang marang nilai buku|Zimmer Biomet - Utang-utang marang kapitalisasi buku|CooperSurgical (COO) - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku GMED|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku Alphatec Holdings (ATEC)|Utang-utang marang kapitalisasi buku AORT|ENOV - Utang-utang marang aset resik|Utang marang nilai buku Integra LifeSciences|ESTA - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku BBNX|IRADIMED Corp (IRMD) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Embecta Inc. (EMBC)|Rasio utang marang nilai buku Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Utang marang nilai buku|Rasio utang marang aset resik SIBN (si-bone.com)|Orthofix - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Utang-utang marang kapitalisasi buku|TMCI - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Strata Critical Medical Inc|carlsmed.com (CARL) - Rasio utang marang nilai buku|RXST: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik ClearPoint|Utang-utang marang kapitalisasi buku STXS (Stereotaxis Corp)|Utang marang nilai buku Neuronetics, Inc (STIM)|Utang-utang marang kapitalisasi buku SGHT (Sight Sciences, Inc.)|Orchestra BioMed Inc. - Utang-utang marang kapitalisasi buku|ANIK - Rasio utang marang kapitalisasi buku|InspireMD Inc (NSPR) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku zhjmedical.com ZJYL|Vivani Medical (VANI) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku XTNT (Xtant Medical Holdings, Inc.)|Utang-utang marang nilai buku MODD|MYO: Rasio utang marang kapitalisasi buku|Utang marang aset resik Envoy Medical Inc. COCH|Utang marang nilai buku VVOS (Vivos Therapeutics, Inc)|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|Utang-utang marang kapitalisasi buku SINT (SINTX Technologies)|TNON: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Lifeward (LFWD)|AMIX (Autonomix Medical) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IVF|Utang marang nilai buku Bone Biologics Inc|Axonics, Inc. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku BIOL (biolase.com)|DYNT - Rasio utang marang kapitalisasi buku|FNA - Rasio utang marang nilai buku|Utang marang nilai buku INVO Bio INVO